| Financial Year |
March 31 2021 |
| Monetary Funds |
1,596,189,411.21 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
34,085,496.76 |
| Accounts Receivable |
528,238,647.13 |
| Advances to Suppliers |
32,965,062.62 |
| Other Receivables |
559,810,015.02 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
308,542,353.97 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
723,600,821.09 |
| Total Current Assets |
3,795,075,960.38 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
4,502,903.68 |
| Investment Properties |
-- |
| Fixed Assetes |
2,925,773,829.50 |
| Under-construction Projects |
445,318,531.72 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
306,122,557.94 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,033,639.10 |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
12,977,531.80 |
| Sub-Total of Non-Current Assets |
4,267,659,760.59 |
| Total Assets |
8,062,735,720.97 |
| Short-Term Loans |
4,514,255,064.12 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
726,346,968.68 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
55,880,452.48 |
| Taxes Payable |
109,176,247.22 |
| Interest Payable |
1,491,038,489.84 |
| Dividend Payable |
25,369,160.34 |
| Other payables |
3,009,473,249.69 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
2,077,507,415.38 |
| Sub-Total of Current Liabilities |
10,515,243,714.79 |
| Long-term Loans |
1,419,608,333.22 |
| Bonds Payable |
1,449,957,447.70 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
4,271,863,120.76 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
7,182,692,164.22 |
| Total Liabilities |
17,697,935,879.01 |
| Paid-In Capital(Or Share Stock) |
3,540,900,282.00 |
| Capital Surplus |
6,819,717,511.99 |
| Surplus Reserve |
51,329,913.55 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-20,072,670,256.50 |
| Minority Stockholder's Interest |
9,189,788.80 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
-9,644,389,946.84 |
| Owner's Equity（Stockholder's Equity） |
-9,635,200,158.04 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
8,062,735,720.97 |
